What's the latest on the Johnson and Johnson COVID 19 Vaccine?

What's the latest on the Johnson and Johnson COVID 19 Vaccine?A third Covid-19 vaccine, one made by Johnson & Johnson, could be authorized for use in the United States in the near future.  The vaccine was made through a collaboration of J&J's Belgium-based vaccine division, Janssen Pharmaceutical, and Beth Israel Deaconess Medical Center, and it works a bit differently.Johnson & Johnson's Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, the company announced Friday.The vaccine is 85% effective overall at preventing hospitalization and death in all regions where it was tested.Its efficacy against moderate and severe disease ranged from one country to another: 72% in the US, 66% in Latin America and 57% in South Africa. This was measured starting one month after the shot.In South Africa, 95% of cases in the trial were due to a variant known as B.1.351, which is known to be more contagious and carries mutations that may make the virus less susceptible to the antibody immune response -- including antibodies prompted by vaccination.Even those who got moderate cases of Covid-19 in the trial tended to develop a milder course and fewer symptoms, said Dr. Mathai Mammen, Janssen's global head of research and development.From one month after the shot, all hospitalizations and deaths occurred in the placebo group.Support the Podcast:  https://www.buzzsprout.com/1590358/support Closing of ReThinkBuzzsprout - Let's get your podcast launched! Start for FREEBuzzsprout - Let's get your podcast launched! Start for FREEDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show